About: One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch (gsw) im März 2000 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в березні 2000 (uk) artículu científicu espublizáu en marzu de 2000 (ast) scientific article published on 01 March 2000 (en)
publication date	wds:Q73658729-3CAAF68F-AA20-48E3-B615-3A601FBAB80B
publication date	2000-03-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73658729-100E6FB5-057A-45D5-A1A4-75AC1FE285B7 wds:Q73658729-129900E3-5445-489F-8433-7D4A81B6DD93 wds:Q73658729-169D50EF-8E5C-4040-98DE-8391C0DCDC19 wds:Q73658729-3CBBE4C5-D332-45C0-A9FA-23C31BB0ECA5 wds:Q73658729-3F71E3A2-007A-4A24-8992-C9F8498CD90C wds:Q73658729-47AADE80-C909-4F93-9D86-C204DA887584 wds:Q73658729-4D82B880-AF02-4FA8-B724-0A1442DB82EF wds:Q73658729-51BB3774-4BB2-4320-A459-D26B42655E75 wds:Q73658729-59FC8B70-0D7F-40CF-8B90-DE0A8E8A14A2 wds:Q73658729-5D14F8CE-4BFD-4128-9DD2-7ED1405506BA wds:Q73658729-643570FF-4219-45E3-8E8A-86013E7EA7AD wds:Q73658729-659E654C-FF52-4AF6-9A1A-BEAAB6664F34 wds:Q73658729-69EBB0C1-F70E-446B-8A3F-6E88A22DC286 wds:Q73658729-6FD12F4C-000F-4F86-9318-902175706AE5 wds:Q73658729-861EDCB4-584A-4E67-A80D-F8CBD5CF8116 wds:Q73658729-BC783740-B32B-4AD9-AD61-5DE35687522E wds:Q73658729-D93A5156-D211-494C-B010-58090273E82B wds:Q73658729-DDEEE7A6-2BD0-47CD-9BD0-D17A0E008CB3 wds:Q73658729-E5BE5183-A3CD-4C09-BB00-F7B839ED50CD wds:Q73658729-FCBB9B3E-3990-42FA-9C56-51E649A3E439
cites work	Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18–0647 (tetrahydrolipstatin) Medical hazards of obesity Long-term weight loss: the effect of pharmacologic agents Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Waist circumference as a measure for indicating need for weight management. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. International trial of long-term dexfenfluramine in obesity. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years Obesity, weight loss and prognosis in type 2 diabetes. Obesity in Britain: gluttony or sloth? Gallstones: pathogenesis Valvular heart disease associated with fenfluramine-phentermine Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers Waist circumference as a screening tool for cardiovascular risk factors: evaluation of receiver operating characteristics (ROC) The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia Evidence for success of caloric restriction in weight loss and control. Summary of data from industry
author name string	wds:Q73658729-17261497-52EA-427F-A125-0BE09C282DCB wds:Q73658729-46752D12-51F7-41F6-BDBA-D2F0BAF00896 wds:Q73658729-5CC40E12-51AC-4A06-AC05-D1726B24D4AF wds:Q73658729-9BC47C6E-D9B8-49D2-BC6F-F8E569128527 wds:Q73658729-EEE84D53-96FF-4C2C-A3C7-A8F1ADBA8EB4
author name string	G Williams W P James N Finer M E Lean P G Kopelman
rdfs:label	One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (en) One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (nl)
skos:prefLabel	One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (en) One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (nl)
name	One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (en) One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (nl)
title	wds:Q73658729-E2CA5605-115E-4EBF-A975-D99A766F3ABF
title	One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor (en)
page(s)	wds:Q73658729-9248C154-C89A-49FF-94BD-F5FAECF2F22D
page(s)	306-313
instance of	wds:Q73658729-1BDAAE32-24FE-4E99-A4F0-28C494B6773C
instance of	scholarly article
main subject	wds:Q73658729-5D76591F-02A0-4F04-BA50-3D5356A7D434 wds:Q73658729-6B461FC5-E121-4DE4-942D-FCFC3CAE7BF4 wds:Q73658729-93B83B81-AED6-40C7-9233-E2ED93CE1BE3
main subject	placebo epidemiology of obesity triacylglycerol lipase inhibitor
PubMed ID	wds:Q73658729-3CE4351B-890E-445B-87DE-2995F87A79F4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10757623
PubMed ID	10757623
issue	wds:Q73658729-82BCDD99-D43C-4B68-ACFD-6DE973E6E639
volume	wds:Q73658729-6DA429D6-5073-4F23-8DDB-E76965277354
issue	3
volume	24
DOI	wds:Q73658729-0D5B2283-0618-4405-A206-95153430EB0B
DOI	http://dx.doi.org/10.1038/SJ.IJO.0801128
DOI	10.1038/SJ.IJO.0801128
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73658729
is cites work of	Effects of weight loss on serum vitamin D in postmenopausal women Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus Combining behavioral and pharmacological treatments for obesity Long-term drug treatment for obesity: a systematic and clinical review One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study Safety of drug therapies used for weight loss and treatment of obesity Obesity in Older Adults: Technical Review and Position Statement of the American Society for Nutrition and NAASO, The Obesity Society 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials Orlistat: its current status as an anti-obesity drug Impact of orlistat-induced weight loss on diastolic function and heart rate variability in severely obese subjects with diabetes

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software